Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | FHND5071 |
Synonyms | |
Therapy Description |
FHND5071 inhibits RET, which decreases downstream signaling and potentially results in reduced cell proliferation and tumor growth (Cancer Res (2023) 83 (8_Supplement): LB330). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
FHND5071 | FHND 5071|FHND-5071 | RET Inhibitor 53 | FHND5071 inhibits RET, which decreases downstream signaling and potentially results in reduced cell proliferation and tumor growth (Cancer Res (2023) 83 (8_Supplement): LB330). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|---|---|---|---|---|---|---|
RET V804M | Advanced Solid Tumor | predicted - sensitive | FHND5071 | Preclinical - Cell culture | Actionable | In a preclinical study, FHND5071 inhibited Ret phosphorylation and proliferation in cells expressing RET V804M in culture (Cancer Res (2023) 83 (8_Supplement): LB330). | detail... |
RET M918T | Advanced Solid Tumor | predicted - sensitive | FHND5071 | Preclinical - Cell culture | Actionable | In a preclinical study, FHND5071 inhibited Ret phosphorylation and proliferation in cells expressing RET M918T in culture (Cancer Res (2023) 83 (8_Supplement): LB330). | detail... |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|